CASSIE LEMASTER: Open Payments
NPI 1528634573 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$747 in 37 payments from 8 companies in 2025. Trend: 2023 $713 · 2024 $421 · 2025 $747
Food & beverage: $747
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 14 | $205 |
| Collegium Pharmaceutical, Inc. | 9 | $151 |
| SI-BONE, INC. | 2 | $145 |
| Forte Bio-Pharma LLC | 5 | $107 |
| Saluda Medical Americas, Inc. | 2 | $45 |
| AppliedVR Inc | 2 | $37 |
| Valinor Pharma, LLC | 2 | $37 |
| Biogen, Inc. | 1 | $21 |
Products named: RELISTOR, Belbuca, PROLATE, Evoke, RelieVRx, MOVANTIK, TANLOR, SKYCLARYS.
Industry payments across OK — which companies pay providers there.
